Forrester Research: Forrester Retail Insights Healthcare First Look: Research & Event Highlights From Forrester

 18 Mar. 2003
They Said It
"WellPoint is sending out coupons to get members to try Claritin on their nickel. It shows that in pharmacy you have to align financial incentives to change patient behavior."
-- Ann Mond Johnson, President of Subimo

Will Web Services Kill Claims Intermediaries?
Eric Brown is out to find the answer. In his upcoming report, Eric is evaluating the technologies and business models that will alter the transaction landscape. To participate or learn more about his research, email Eric at ebrown@forrester.com.

Where You Will Find Us:
Mike Barrett chairs a clinical trials technology panel at Bio-IT World in Boston on March 25 at 2:00 p.m.

Liz Boehm will be at DTC National, a forum for DTC thought leaders, in Boston on March 25-27.

Eric Brown will be on the West Coast in early April. Contact Carrie Cerullo at ccerullo@forrester.com if you want to meet with him.

Forrester Does Custom Projects
We recently executed two survey projects for clients. In the first we dug into pharma marketing executives' data requirements, and in the second we explored benefits executives' employee-portal preferences. In both cases we crafted the survey, evaluated the data, and delivered strategic advice to the client.

What important questions can we answer for you? Contact me at bradholmes@forrester.com to learn more about our custom work.

New Research In The Works
"How To Fix Broken Health Plan Member Services, Part Two," by Liz Boehm

"Will Web Services Kill Claims Intermediaries?" by Eric Brown

"Medical Device Firms Will Thrive On Healthcare Unbound," by Mike Barrett

"Forrester Wave: Finding The Best Consumer Directed Health Plan," by Brad Holmes

How Will Pharma Fill Its Clinical Trials?
How Will Pharma Fill Its Clinical Trials?

Healthcare First Look at cross-entity customer service.
Health plans today face a higher hurdle to satisfying customers than most firms because they commonly outsource major service operations to prescription and disease management vendors. Thus, crafting a unified, cross-channel -- and cross-entity -- customer service experience is key to preventing member frustration and enabling higher use of low-cost self-service options.


Leading Plan Sites Attract More Member Visits What should health plans do? Forrester analyst Liz Boehm says, "Because plans can't fix problems they can't identify, we developed a customer experience scorecard that pinpoints common service failures. Critical cross-channel service capabilities include consistency of data and language, the ability to save a transaction midstream, and in-process status notices, all of which enable customers to make incremental progress at each step of a cross-channel service scenario."

Later this month, look for Liz's second brief in her three-part series on fixing health plans' member services, in which she reveals Forrester's scoring of the cross-entity service capabilities of prominent plans.

Out-of-reach drug costs are a hot consumer issue and Forrester expects many major health plans to fuel the fire by deploying new side-by-side drug comparison tools on their Web sites in 2003. With some personalization enhancements, such as better configuration tools from companies like Dell, these apps will give consumers bold new powers like the ability to distinguish drugs by side-effect severity, sort them by personal preferences, and understand pricing nuances. We expect increasing cost and quality transparency to put formulary practices under the microscope this year.

The EMR tipping point is upon us, and some dominoes are going to finally fall. According to Eric Brown, "EMR adoption is accelerating due to market forces, not the several technological improvements these apps have seen in the past couple of years. First, doctors follow their peers, and the herd is moving. Then you have HIPAA security rules that demand automation. Finally, payment for quality from firms like WellPoint and GE means less money for providers that don't automate."

With more EMRs in use and the FDA proposing bar coding for drugs, computerized physician order entry, CPOE, will begin to move from pipe dream to reality. Mike Barrett believes that to avoid errors upfront, EMRs must link with clinical decision support vendors to build drug-interaction and evidence-based medicine edits into the prescribing process.

What happens when EMRs meet clinical trials? By mid-decade, Forrester foresees a major shift in the way drug firms fill their clinical trial rosters. When we compare the database features of the four major contenders in the recruitment services race, EMR vendors that collaborate with consortia of institutions make the most compelling story. Mike Barret says, "Not only will these EMR-driven consortia have fresher and more relevant data for recruiting, but they will also be able to underprice the other contenders. Pharma should begin to line up its EMR relationships now."

Our latest consumer data is in, and we will now begin profiling consumers' technology ownership and attitudes by disease and by health plan. Let me know what you want to learn from this new resource or what additional services you need us to deliver by replying to this email address with your thoughts. Thanks.


Brad Holmes
Research Director

P.S. Are there other people in your organization who should receive Healthcare First Look? They can subscribe via the link to our email subscriptions page below.



We hope you like Healthcare First Look but if not, please unsubscribe. If you would like to subscribe to Healthcare First Look, please go to our Emails and Alerts page. If you have colleagues who should receive this newsletter, they also can sign up on this page.

Entire contents © 1997-2003, Forrester Research, Inc. All rights reserved. Forrester, Forrester eResearch, Forrester Oval Program, Forrester Wave, WholeView, Technographics, TechStrategy, and TechRankings are trademarks of Forrester Research, Inc. All other trademarks are the property of their respective companies. Forrester clients may make one attributed copy or slide of each figure contained herein. Additional reproduction is strictly prohibited. For additional reproduction rights and usage information, go to www.forrester.com. Information is based on best available resources. Opinions reflect judgment at the time and are subject to change.